Ghost Tree Capital as of March 31, 2016
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 49 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| ACADIA Pharmaceuticals (ACAD) | 6.7 | $12M | 425k | 27.96 | |
| SPDR S&P Biotech (XBI) | 6.2 | $11M | 220k | 50.17 | |
| Celgene Corporation | 5.1 | $9.0M | 90k | 100.09 | |
| Edwards Lifesciences (EW) | 5.0 | $8.8M | 100k | 88.21 | |
| Boston Scientific Corporation (BSX) | 4.8 | $8.5M | 450k | 18.81 | |
| iShares Russell 2000 Index (IWM) | 4.7 | $8.3M | 75k | 110.63 | |
| Horizon Pharma | 4.0 | $7.0M | 425k | 16.57 | |
| Pacific Biosciences of California (PACB) | 3.4 | $6.0M | 700k | 8.50 | |
| Abbvie (ABBV) | 3.2 | $5.7M | 100k | 57.12 | |
| Agios Pharmaceuticals (AGIO) | 3.2 | $5.7M | 140k | 40.60 | |
| Alexion Pharmaceuticals | 3.1 | $5.6M | 40k | 139.22 | |
| Teva Pharmaceutical Industries (TEVA) | 3.0 | $5.4M | 100k | 53.51 | |
| Mirati Therapeutics | 3.0 | $5.4M | 250k | 21.40 | |
| Sage Therapeutics (SAGE) | 2.9 | $5.1M | 160k | 32.06 | |
| Spectranetics Corporation | 2.9 | $5.1M | 350k | 14.52 | |
| Ophthotech | 2.9 | $5.1M | 120k | 42.27 | |
| iShares Dow Jones US Health Care (IHF) | 2.7 | $4.8M | 40k | 121.97 | |
| Nevro (NVRO) | 2.4 | $4.2M | 75k | 56.27 | |
| Nanostring Technologies (NSTGQ) | 1.9 | $3.4M | 225k | 15.22 | |
| NuVasive | 1.9 | $3.4M | 70k | 48.66 | |
| Integra LifeSciences Holdings (IART) | 1.9 | $3.4M | 50k | 67.36 | |
| BioMarin Pharmaceutical (BMRN) | 1.9 | $3.3M | 40k | 82.48 | |
| iShares Dow Jones US Medical Dev. (IHI) | 1.7 | $3.1M | 25k | 122.48 | |
| ResMed (RMD) | 1.6 | $2.9M | 50k | 57.82 | |
| Portola Pharmaceuticals | 1.6 | $2.9M | 140k | 20.40 | |
| Valeant Pharmaceuticals Int | 1.5 | $2.6M | 100k | 26.30 | |
| Dbv Technologies S A (DBVT) | 1.5 | $2.6M | 45k | 57.40 | |
| Wright Medical Group Nv | 1.2 | $2.1M | 125k | 16.60 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.1 | $2.0M | 25k | 79.48 | |
| St. Jude Medical | 1.1 | $2.0M | 37k | 55.01 | |
| Medtronic (MDT) | 1.1 | $2.0M | 27k | 74.99 | |
| Entellus Medical Cm | 1.1 | $2.0M | 110k | 18.19 | |
| Achillion Pharmaceuticals | 1.1 | $1.9M | 250k | 7.72 | |
| Veracyte (VCYT) | 1.0 | $1.8M | 342k | 5.40 | |
| Cynapsus Therapeutics | 1.0 | $1.8M | 152k | 11.90 | |
| GenMark Diagnostics | 0.9 | $1.6M | 300k | 5.27 | |
| iShares Dow Jones US Pharm Indx (IHE) | 0.8 | $1.3M | 9.8k | 136.94 | |
| Tandem Diabetes Care | 0.7 | $1.3M | 150k | 8.71 | |
| Lion Biotechnologies | 0.7 | $1.3M | 250k | 5.08 | |
| Alcobra | 0.6 | $1.1M | 300k | 3.79 | |
| Chiasma | 0.4 | $687k | 75k | 9.16 | |
| Endo International (ENDPQ) | 0.4 | $678k | 24k | 28.13 | |
| Vitae Pharmaceuticals | 0.4 | $671k | 101k | 6.63 | |
| Akari Therapeutics | 0.4 | $653k | 47k | 14.01 | |
| Heron Therapeutics (HRTX) | 0.3 | $475k | 25k | 19.00 | |
| Adaptimmune Therapeutics (ADAP) | 0.2 | $407k | 50k | 8.14 | |
| Clovis Oncology | 0.2 | $355k | 19k | 19.19 | |
| Strongbridge Bioph shs usd | 0.2 | $332k | 73k | 4.57 | |
| Ocera Therapeutics | 0.1 | $132k | 45k | 2.93 |
